Stryde Research

Protocol Dev: Is care management missing from the GLP-1 drug discourse? https://lnkd.in/ewJY3dHv

Protocol Dev: Patient related outcome measures (PROMs) in long term conditions—is it time to bring them into routine clinical practice? https://lnkd.in/ezTPYQfZ

Clinical Sites: Diversity Action Plans for Clinical Trials: Evaluating FDA's Draft Guidance https://lnkd.in/e7jBjUqn Happy to the see the FDA emphasizing the importance of clinical trial diversity.

Rare Disease Tech: A Clinical Trial Leads to the Approval of a Crucial Multiple Myeloma Treatment https://lnkd.in/etE_HD_Z Excited to see this!

Opinion: Can AI help ease medicine’s empathy problem? https://lnkd.in/emwKGnKM Artificial Intelligence (AI) is revolutionizing the field of medicine, bringing forth unprecedented advancements and innovations that are transforming patient care and clinical practices. From predictive analytics that anticipate health issues before they arise, to powerful algorithms that enhance diagnostic accuracy, AI is enabling healthcare professionals to provide more precise, efficient, and personalized treatment. Furthermore, AI-driven research is accelerating drug discovery and development, ultimately leading to quicker, more effective therapeutics for patients worldwide. The future of medicine is undoubtedly being reshaped by these groundbreaking technologies. #HealthTech #MedicalInnovation #FutureOfMedicine

Federal agencies implicitly and explicitly exclude people with disabilities from clinical trials. This doesn’t help with ongoing DEI efforts.

Clinical trials exclude disabled Americans because federal agencies failed them, new report finds https://lnkd.in/gcJ7FNMD In the ever-evolving landscape of clinical research, it is our utmost responsibility to continually seek innovative approaches to inclusivity. By embracing diverse populations, we ensure that our findings are both comprehensive and applicable to all. This commitment not only enhances the integrity of our research but also promotes equitable healthcare outcomes. Let us advance together towards a more inclusive future in clinical research. #InclusiveResearch #DiversityInScience #EquitableHealthcare

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses https://lnkd.in/eTvA8w_c In the journey of managing any disease, having compassionate and dedicated physicians by your side is paramount. Their empathetic approach not only enhances patient trust and compliance but also significantly improves overall health outcomes. By fostering open communication and providing personalized care, caring physicians make the challenging path of disease management more navigable and hopeful. #HealthcareExcellence #PatientCenteredCare #CompassionInMedicine

With pharma in ‘catbird seat,’ biotechs get less upfront in drug partnerships In the current landscape of reduced funding, biotechs must adopt more strategic approaches to their clinical development plans. Our team is well-equipped to guide you through optimizing resources, enhancing efficiency, and ensuring the success of your clinical trials. Let us partner with you to navigate these challenges and achieve your goals. #ClinicalInnovation #BiotechStrategy #SmartFunding

Minority Groups Remain Underrepresented in Vitiligo Trials, Study Finds (https://lnkd.in/eRwvxUB) Clinical trials are the backbone of medical advancements, yet they remain fundamentally flawed when lacking diverse representation. It is imperative to include individuals from all backgrounds to ensure the findings are universally applicable and beneficial. Diverse clinical trials lead to better healthcare outcomes, uncovering unknown drug interactions, and providing insights into how treatments can be tailored for different genetic makeups. We cannot achieve true progress if our research does not reflect the full spectrum of humanity. #InclusiveResearch #HealthEquity #ClinicalTrialsMatter